LRRK2 and Parkinson disease: Similarly, the levels of LRRK2 protein in PD patients’ B cells, T cells (CD4+, CD8+, and T regulatory cells), CD14+, and CD16+ monocytes were increased compared with healthy controls (Bliederhaeuser et al., 2016; Cook et al., 2017).